Exelixis Stock Buy Hold or Sell Recommendation
| EXEL Stock | USD 23.29 0.42 1.84% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Exelixis is 'Strong Hold'. Macroaxis provides Exelixis buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Exelixis positions. The advice algorithm takes into account all of Exelixis' available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Exelixis' buy or sell advice are summarized below:
Real Value 24.21 | Target Price 25.76 | Hype Value 23.27 | Market Value 23.29 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Exelixis given historical horizon and risk tolerance towards Exelixis. When Macroaxis issues a 'buy' or 'sell' recommendation for Exelixis, the advice is generated through an automated system that utilizes algorithms and statistical models.
Exelixis |
Execute Exelixis Buy or Sell Advice
The Exelixis recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Exelixis. Macroaxis does not own or have any residual interests in Exelixis or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Exelixis' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Hold
Market Performance | Insignificant | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Very Low | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Strong | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Exelixis Trading Alerts and Improvement Suggestions
| Exelixis generated a negative expected return over the last 90 days | |
| Exelixis has a strong financial position based on the latest SEC filings | |
| Over 91.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from simplywall.st: Exelixis, Inc.s Earnings Havent Escaped The Attention Of Investors |
Exelixis Returns Distribution Density
The distribution of Exelixis' historical returns is an attempt to chart the uncertainty of Exelixis' future price movements. The chart of the probability distribution of Exelixis daily returns describes the distribution of returns around its average expected value. We use Exelixis price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Exelixis returns is essential to provide solid investment advice for Exelixis.
| Mean Return | -0.2 | Value At Risk | -1.66 | Potential Upside | 1.55 | Standard Deviation | 1.33 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Exelixis historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Exelixis Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Exelixis is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Exelixis backward and forwards among themselves. Exelixis' institutional investor refers to the entity that pools money to purchase Exelixis' securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Nuveen Asset Management, Llc | 2023-12-31 | 3.5 M | Charles Schwab Investment Management Inc | 2023-12-31 | 3.4 M | Jacobs Levy Equity Management, Inc. | 2023-09-30 | 3.3 M | First Trust Advisors L.p. | 3.2 M | Fmr Inc | 2023-12-31 | 3.1 M | Norges Bank | 3.1 M | Bank Of New York Mellon Corp | 2023-12-31 | 3 M | Fuller & Thaler Asset Management Inc | 2023-12-31 | 2.6 M | Pictet Asset Manangement Sa | 2.2 M | Blackrock Inc | 2023-12-31 | 36 M | Vanguard Group Inc | 2023-12-31 | 31.7 M |
Exelixis Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | (47.7M) | 52.6M | 343.1M | (161.2M) | (239.7M) | (227.7M) | |
| Free Cash Flow | 514.1M | 178.6M | 336.6M | 224.2M | 170.4M | 178.9M | |
| Depreciation | 8.3M | 9.1M | 13.6M | 20.9M | 25.7M | 27.0M | |
| Capital Expenditures | 12.8M | 30.3M | 64.2M | 138.5M | 163.0M | 171.1M | |
| Net Income | 321.0M | 111.8M | 231.1M | 182.3M | 207.8M | 218.2M | |
| End Period Cash Flow | 268.1M | 320.8M | 663.9M | 502.7M | 263.0M | 191.9M | |
| Change To Inventory | (5.7M) | (21.9M) | (13.2M) | (11.7M) | (13.0M) | (12.3M) | |
| Other Non Cash Items | 2.9M | 7.9M | 28.8M | 125.0M | 140.7M | 147.7M | |
| Investments | (574.4M) | (100.9M) | 21.3M | (386.0M) | (334.5M) | (317.8M) | |
| Change Receivables | (89.9M) | 43.7M | (42.5M) | 66.8M | 76.9M | 80.7M | |
| Change To Netincome | 127.7M | 123.4M | 195.1M | 153.9M | 177.0M | 185.9M |
Exelixis Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Exelixis or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Exelixis' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Exelixis stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.14 | |
β | Beta against NYSE Composite | 0.38 | |
σ | Overall volatility | 1.43 | |
Ir | Information ratio | -0.03 |
Exelixis Volatility Alert
Exelixis exhibits very low volatility with skewness of -1.32 and kurtosis of 3.47. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Exelixis' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Exelixis' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Exelixis Fundamentals Vs Peers
Comparing Exelixis' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Exelixis' direct or indirect competition across all of the common fundamentals between Exelixis and the related equities. This way, we can detect undervalued stocks with similar characteristics as Exelixis or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Exelixis' fundamental indicators could also be used in its relative valuation, which is a method of valuing Exelixis by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Exelixis to competition |
| Fundamentals | Exelixis | Peer Average |
| Return On Equity | 0.0874 | -0.31 |
| Return On Asset | 0.0355 | -0.14 |
| Profit Margin | 0.11 % | (1.27) % |
| Operating Margin | 0.17 % | (5.51) % |
| Current Valuation | 6.05 B | 16.62 B |
| Shares Outstanding | 294.8 M | 571.82 M |
| Shares Owned By Insiders | 2.40 % | 10.09 % |
| Shares Owned By Institutions | 90.58 % | 39.21 % |
| Number Of Shares Shorted | 6.83 M | 4.71 M |
| Price To Earning | 48.17 X | 28.72 X |
| Price To Book | 3.05 X | 9.51 X |
| Price To Sales | 3.78 X | 11.42 X |
| Revenue | 1.83 B | 9.43 B |
| Gross Profit | 1.55 B | 27.38 B |
| EBITDA | 196.6 M | 3.9 B |
| Net Income | 207.76 M | 570.98 M |
| Cash And Equivalents | 1.53 B | 2.7 B |
| Cash Per Share | 4.77 X | 5.01 X |
| Total Debt | 189.94 M | 5.32 B |
| Debt To Equity | 0.07 % | 48.70 % |
| Current Ratio | 6.08 X | 2.16 X |
| Book Value Per Share | 7.48 X | 1.93 K |
| Cash Flow From Operations | 333.32 M | 971.22 M |
| Short Ratio | 2.74 X | 4.00 X |
| Earnings Per Share | 0.65 X | 3.12 X |
| Price To Earnings To Growth | 1.69 X | 4.89 X |
| Target Price | 26.74 | |
| Number Of Employees | 1.31 K | 18.84 K |
| Beta | 0.57 | -0.15 |
| Market Capitalization | 6.74 B | 19.03 B |
| Total Asset | 2.94 B | 29.47 B |
| Retained Earnings | (173.35 M) | 9.33 B |
| Working Capital | 923.68 M | 1.48 B |
Note: Disposition of 23304 shares by Michael Morrissey of Exelixis at 21.51 subject to Rule 16b-3 [view details]
Exelixis Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Exelixis . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 38401.68 | |||
| Daily Balance Of Power | 0.8936 | |||
| Rate Of Daily Change | 1.02 | |||
| Day Median Price | 23.24 | |||
| Day Typical Price | 23.25 | |||
| Price Action Indicator | 0.26 | |||
| Period Momentum Indicator | 0.42 |
About Exelixis Buy or Sell Advice
When is the right time to buy or sell Exelixis? Buying financial instruments such as Exelixis Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.| 2021 | 2022 | 2023 | 2024 (projected) | Short and Long Term Debt Total | 51.3M | 190.2M | 189.9M | 156.7M | Other Stockholder Equity | 2.4B | 2.5B | 2.4B | 1.4B |
Use Investing Ideas to Build Portfolios
In addition to having Exelixis in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run USD Crypto Fund Thematic Idea Now
USD Crypto Fund
Fund from digital currency traded on multiple global exchanges in US dollors. The USD Crypto Fund theme has 24 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize USD Crypto Fund Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Exelixis Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Exelixis Stock please use our How to buy in Exelixis Stock guide.Note that the Exelixis information on this page should be used as a complementary analysis to other Exelixis' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Complementary Tools for Exelixis Stock analysis
When running Exelixis' price analysis, check to measure Exelixis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Exelixis is operating at the current time. Most of Exelixis' value examination focuses on studying past and present price action to predict the probability of Exelixis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Exelixis' price. Additionally, you may evaluate how the addition of Exelixis to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |
Is Exelixis' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Exelixis. If investors know Exelixis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Exelixis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.99) | Earnings Share 0.65 | Revenue Per Share 5.753 | Quarterly Revenue Growth 0.131 | Return On Assets 0.0355 |
The market value of Exelixis is measured differently than its book value, which is the value of Exelixis that is recorded on the company's balance sheet. Investors also form their own opinion of Exelixis' value that differs from its market value or its book value, called intrinsic value, which is Exelixis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Exelixis' market value can be influenced by many factors that don't directly affect Exelixis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Exelixis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Exelixis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Exelixis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.